Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors (Q38787483)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 March 2016

Language	Label	Description	Also known as
English	Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors	scientific article published on 10 March 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1 reference

based on heuristic

inferred from title

Martin Ingelsson

8

object named as

Martin Ingelsson

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

6

object named as

Lars Lannfelt

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

author name string

Gabriel Gustafsson

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Fredrik Eriksson

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Christer Möller

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Tomás Lopes da Fonseca

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Tiago F Outeiro

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Joakim Bergström

7

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

publication date

10 March 2016

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

language of work

Cellular and Molecular Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

121-131

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses.

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Alpha-synuclein locus duplication as a cause of familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

The small GTPase Rab11 co-localizes with α-synuclein in intracellular inclusions and modulates its aggregation, secretion and toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Accumulation of toxic α-synuclein oligomer within endoplasmic reticulum occurs in α-synucleinopathy in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Antibody uptake into neurons occurs primarily via clathrin-dependent Fcγ receptor endocytosis and is a prerequisite for acute tau protein clearance.

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Different species of alpha-synuclein oligomers induce calcium influx and seeding.

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Heat‐shock protein 70 modulates toxic extracellular α‐synuclein oligomers and rescues trans‐synaptic toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Exosomal cell-to-cell transmission of alpha synuclein oligomers.

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation.

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Distinct Therapeutic Mechanisms of Tau Antibodies: Promoting Microglial Clearance Versus Blocking Neuronal Uptake

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly.

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Identification of two distinct synucleins from human brain

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Systematic comparison of the effects of alpha-synuclein mutations on its oligomerization and aggregation.

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Intravesicular localization and exocytosis of alpha-synuclein and its aggregates.

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Alterations of Fc gamma receptor I and Toll-like receptor 4 mediate the antiinflammatory actions of microglia and astrocytes after adrenaline-induced blood-brain barrier opening in rats

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Antibodies against alpha-synuclein reduce oligomerization in living cells

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Expression of Fc gamma receptors on astroglial cell lines and their role in the central nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Formation of toxic oligomeric alpha-synuclein species in living cells

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

The paradoxical cell biology of alpha-Synucle

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

ESCRT-mediated uptake and degradation of brain-targeted α-synuclein single chain antibody attenuates neuronal degeneration in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Α-synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

In vivo demonstration that alpha-synuclein oligomers are toxic

1 reference

https://api.crossref.org/works/10.1007%2FS10571-016-0352-5

21 January 2018

Identifiers

10.1007/S10571-016-0352-5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38787483&oldid=2202071725"